Berman Howard 4
4 · Atea Pharmaceuticals, Inc. · Filed Jun 24, 2025
Insider Transaction Report
Form 4
Berman Howard
Director
Transactions
- Award
Stock Option (Right to Buy)
2025-06-20+164,800→ 164,800 totalExercise: $3.25Exp: 2035-06-19→ Common Stock (164,800 underlying)
Footnotes (1)
- [F1]The option vests and becomes exercisable in thirty-six (36) equal monthly installments following June 20, 2025 such that the option is fully vested on June 20, 2028.